• Explore /
  • Poster
  • / Preclinical evaluation of LCK as a novel therapeutic target in YAP-activated and FGFR2-altered cholangiocarcinoma.

Preclinical evaluation of LCK as a novel therapeutic target in YAP-activated and FGFR2-altered cholangiocarcinoma.

Abstract Poster

Authors

null

Caitlin Conboy

Mayo Clinic, Division of Medical Oncology, Rochester, MN

Caitlin Conboy , Jennifer Yonkus , EeeLN Buckarma , Dong-Gi Mun , Nathan Werneburg , Ryan Watkins , Yi Guo , Juan Wang , Daniel O'Brien , Rogier Buijsman , Diep Vu , Jos De Man , Sumera Ilyas , Mark J. Truty , Mitesh J. Borad , Akhilesh Pandey , Gregory J. Gores , Rory L. Smoot

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

DOI

10.1200/JCO.2022.40.4_suppl.463

Abstract #

463

Poster Bd #

D2

Abstract Disclosures

Similar Posters

First Author: Shohei Takaichi

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Discovery of novel interactions with LCK in cholangiocarcinoma using proximity-dependent biotinylation.

Discovery of novel interactions with LCK in cholangiocarcinoma using proximity-dependent biotinylation.

First Author: Jennifer L Tomlinson

First Author: Milind M. Javle

First Author: Yanzhe Xia